Management
Horst G. Zerbe, Ph.D., President and CEO, Prior to founding IntelGenx, he served as the president of Smartrix Technologies Inc. in Montreal, and as Vice President of R&D at LTS Lohmann Therapy Systems in West Caldwell, NJ. He holds over 40 patents in drug delivery related fields and has published numerous scientific papers in recognized journals.
Paul Simmons, AFCA, Chief Financial Officer, has held CFO and VP-Finance & Administration positions with several manufacturers in agricultural machinery, hearing aids, and classic English knitwear. He brings a wealth of business and finance experience in aligning financial planning with company objectives, enhancing corporate value and financial performance, and has consistently exceeded targets in delivering fiscal gains and corporate growth.
James Wittenberg, R.Ph., MS., Senior Vice President, Business Development, joined IntelGenx in 2007 and is responsible for Licensing and Acquisitions, and Strategic Alliances. Prior to joining IntelGenx he served as Director, Business Development at the US affiliate of Schwarz Pharma. He received his BS and MS degrees in Pharmacy from the University of Wisconsin and has more than 20 years experience in business development and market research within the pharmaceutical industry.
Nadine Paiement, M.Sc., Director, Pharmaceutical R&D, holds a M.Sc. degree in Polymer Chemistry from Sherbrooke University, and is co-inventor of IntelGenx’ trilayer technology.